vs
Side-by-side financial comparison of NOVAVAX INC (NVAX) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $147.3M, roughly 1.0× NOVAVAX INC). On growth, NOVAVAX INC posted the faster year-over-year revenue change (66.8% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $-41.6M). Over the past eight quarters, NOVAVAX INC's revenue compounded faster (25.3% CAGR vs 5.1%).
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
NVAX vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $147.3M | $151.1M |
| Net Profit | $17.5M | — |
| Gross Margin | 85.0% | 17.8% |
| Operating Margin | 9.7% | 2.3% |
| Net Margin | 11.9% | — |
| Revenue YoY | 66.8% | 3.6% |
| Net Profit YoY | 121.6% | — |
| EPS (diluted) | $0.28 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $147.3M | $151.1M | ||
| Q3 25 | $70.4M | $126.8M | ||
| Q2 25 | $239.2M | $132.5M | ||
| Q1 25 | $666.5M | $135.7M | ||
| Q4 24 | $88.3M | $145.8M | ||
| Q3 24 | $84.5M | $122.3M | ||
| Q2 24 | $415.5M | $130.8M | ||
| Q1 24 | $93.9M | $136.8M |
| Q4 25 | $17.5M | — | ||
| Q3 25 | $-202.4M | $1.6M | ||
| Q2 25 | $106.5M | $-17.2M | ||
| Q1 25 | $518.6M | $7.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-121.3M | $4.7M | ||
| Q2 24 | $162.4M | $8.3M | ||
| Q1 24 | $-147.6M | $7.1M |
| Q4 25 | 85.0% | 17.8% | ||
| Q3 25 | 69.5% | 15.1% | ||
| Q2 25 | 93.6% | 3.9% | ||
| Q1 25 | 97.9% | 22.0% | ||
| Q4 24 | 58.5% | 22.8% | ||
| Q3 24 | 28.3% | 18.5% | ||
| Q2 24 | 88.9% | 22.3% | ||
| Q1 24 | 36.9% | 21.5% |
| Q4 25 | 9.7% | 2.3% | ||
| Q3 25 | -252.7% | -2.7% | ||
| Q2 25 | 42.2% | -15.6% | ||
| Q1 25 | 77.4% | 6.2% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -158.6% | 3.1% | ||
| Q2 24 | 38.7% | 6.9% | ||
| Q1 24 | -154.3% | 5.5% |
| Q4 25 | 11.9% | — | ||
| Q3 25 | -287.3% | 1.2% | ||
| Q2 25 | 44.5% | -13.0% | ||
| Q1 25 | 77.8% | 5.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -143.5% | 3.9% | ||
| Q2 24 | 39.1% | 6.3% | ||
| Q1 24 | -157.2% | 5.2% |
| Q4 25 | $0.28 | $0.22 | ||
| Q3 25 | $-1.25 | $0.10 | ||
| Q2 25 | $0.62 | $-1.05 | ||
| Q1 25 | $2.93 | $0.46 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | $-0.76 | $0.28 | ||
| Q2 24 | $0.99 | $0.47 | ||
| Q1 24 | $-1.05 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $735.1M | $92.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-127.8M | $283.8M |
| Total Assets | $1.2B | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $735.1M | $92.5M | ||
| Q3 25 | $762.9M | $80.8M | ||
| Q2 25 | $612.3M | $101.4M | ||
| Q1 25 | $731.5M | $108.3M | ||
| Q4 24 | $923.1M | $105.5M | ||
| Q3 24 | $909.5M | $96.0M | ||
| Q2 24 | $1.0B | $105.6M | ||
| Q1 24 | $480.6M | $115.3M |
| Q4 25 | $-127.8M | $283.8M | ||
| Q3 25 | $-156.7M | $279.6M | ||
| Q2 25 | $37.6M | $289.3M | ||
| Q1 25 | $-75.6M | $321.5M | ||
| Q4 24 | $-623.8M | $319.6M | ||
| Q3 24 | $-526.4M | $314.9M | ||
| Q2 24 | $-431.7M | $321.5M | ||
| Q1 24 | $-867.1M | $332.0M |
| Q4 25 | $1.2B | $342.0M | ||
| Q3 25 | $1.2B | $342.3M | ||
| Q2 25 | $1.3B | $349.5M | ||
| Q1 25 | $1.3B | $379.0M | ||
| Q4 24 | $1.6B | $384.0M | ||
| Q3 24 | $1.7B | $373.5M | ||
| Q2 24 | $1.8B | $376.7M | ||
| Q1 24 | $1.4B | $385.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.5M | $15.5M |
| Free Cash FlowOCF − Capex | $-41.6M | $12.3M |
| FCF MarginFCF / Revenue | -28.2% | 8.2% |
| Capex IntensityCapex / Revenue | 1.4% | 2.1% |
| Cash ConversionOCF / Net Profit | -2.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-250.2M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.5M | $15.5M | ||
| Q3 25 | $107.8M | $12.9M | ||
| Q2 25 | $-127.5M | $14.7M | ||
| Q1 25 | $-185.5M | $11.1M | ||
| Q4 24 | $-87.3M | $20.0M | ||
| Q3 24 | $-144.8M | $9.4M | ||
| Q2 24 | $314.3M | $18.7M | ||
| Q1 24 | $-83.6M | $7.3M |
| Q4 25 | $-41.6M | $12.3M | ||
| Q3 25 | $105.8M | $7.0M | ||
| Q2 25 | $-127.7M | $9.1M | ||
| Q1 25 | $-186.7M | $10.0M | ||
| Q4 24 | $-100.3M | $16.4M | ||
| Q3 24 | $-146.2M | $2.6M | ||
| Q2 24 | $311.4M | $10.1M | ||
| Q1 24 | $-90.4M | $5.6M |
| Q4 25 | -28.2% | 8.2% | ||
| Q3 25 | 150.2% | 5.5% | ||
| Q2 25 | -53.4% | 6.9% | ||
| Q1 25 | -28.0% | 7.4% | ||
| Q4 24 | -113.6% | 11.2% | ||
| Q3 24 | -173.0% | 2.1% | ||
| Q2 24 | 74.9% | 7.7% | ||
| Q1 24 | -96.4% | 4.1% |
| Q4 25 | 1.4% | 2.1% | ||
| Q3 25 | 2.9% | 4.6% | ||
| Q2 25 | 0.1% | 4.2% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 14.8% | 2.5% | ||
| Q3 24 | 1.6% | 5.5% | ||
| Q2 24 | 0.7% | 6.6% | ||
| Q1 24 | 7.3% | 1.3% |
| Q4 25 | -2.25× | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | -1.20× | — | ||
| Q1 25 | -0.36× | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | 1.94× | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
